TrialScientific reports2020
Two-year outcomes of the treat-and-extend regimen using aflibercept for treating diabetic macular oedema.
Yu Cheol Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it